Tyme Technologies ROA 2024

Tyme Technologies Aktienanalyse

What does Tyme Technologies do?

Tyme Technologies Inc is a biopharmaceutical company specializing in the development of cancer drugs. The company was founded in 2011 by Steve Hoffman in New York City. Tyme Technologies Inc aims to provide a solution for the urgent need for new cancer drugs. The business model of Tyme Technologies Inc focuses on research and development of therapies for various types of cancer. The company takes an innovative approach by targeting the metabolism of tumor cells to combat them. The goal is to provide personalized medicine to cancer patients, tailored to their specific cancer types and with fewer side effects. Tyme Technologies has achieved success in various areas and is actively working on establishing cancer treatment products. The company engages in its own research as well as collaborations with other companies and institutions. One of Tyme Technologies' areas of focus is the research and development of drugs for triple-negative breast cancer. This type of cancer is known to be very aggressive and spreads quickly. Tyme Technologies has developed a promising drug called SM-88, which aims to disrupt the metabolic processes in cancer cells, causing them to die. Another significant project of Tyme Technologies is the research and development of drugs for glioma, a particularly aggressive brain tumor for which there are currently no effective therapies. The company has successfully tested the drug SM-88 in a phase II study for this purpose. Tyme Technologies has also focused on cancer treatment in children. The company has conducted clinical trials for the treatment of neuroblastoma and osteosarcoma, both of which are rare and particularly aggressive types of cancer that mainly affect children. In terms of product offerings, Tyme Technologies has introduced various products to the market. One of them is the NLC-001 immunotherapy program, which focuses on activating the body's immune response against cancer cells. The company has also developed a test procedure for personalizing therapy in patients with triple-negative breast cancer, based on the patient's genetic profile. In summary, Tyme Technologies Inc is an emerging biopharmaceutical company specializing in the development of personalized therapies to combat various types of cancer. With its innovative technology, the company has already achieved significant success, particularly in the development of drugs for triple-negative breast cancer and brain tumors. The company continuously collaborates with other companies and institutions and invests in research and development of new cancer drugs in the long term. Tyme Technologies ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Tyme Technologies's Return on Assets (ROA)

Tyme Technologies's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Tyme Technologies's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Tyme Technologies's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Tyme Technologies’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Tyme Technologies stock

What is the Return on Assets (ROA) of Tyme Technologies this year?

The Return on Assets (ROA) of Tyme Technologies is -0.27 undefined this year.

What was the ROA of Tyme Technologies compared to the previous year?

The ROA of Tyme Technologies has increased by 2.14% compared to the previous year.

What consequences do high ROA have for investors of Tyme Technologies?

A high ROA is advantageous for investors of Tyme Technologies, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Tyme Technologies?

A low ROA can be unfavorable for investors of Tyme Technologies as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Tyme Technologies affect the company?

An increase in ROA of Tyme Technologies can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Tyme Technologies impact the company?

A reduction in the ROA of Tyme Technologies can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Tyme Technologies?

Some factors that can influence the ROA of Tyme Technologies include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Tyme Technologies important for investors?

The ROA of Tyme Technologies is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Tyme Technologies take to improve ROA?

To improve ROA, Tyme Technologies can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Tyme Technologies pay?

Over the past 12 months, Tyme Technologies paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Tyme Technologies is expected to pay a dividend of 0 USD.

What is the dividend yield of Tyme Technologies?

The current dividend yield of Tyme Technologies is .

When does Tyme Technologies pay dividends?

Tyme Technologies pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Tyme Technologies?

Tyme Technologies paid dividends every year for the past 0 years.

What is the dividend of Tyme Technologies?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Tyme Technologies located?

Tyme Technologies is assigned to the 'Health' sector.

Wann musste ich die Aktien von Tyme Technologies kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Tyme Technologies from 9/19/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/19/2024.

When did Tyme Technologies pay the last dividend?

The last dividend was paid out on 9/19/2024.

What was the dividend of Tyme Technologies in the year 2023?

In the year 2023, Tyme Technologies distributed 0 USD as dividends.

In which currency does Tyme Technologies pay out the dividend?

The dividends of Tyme Technologies are distributed in USD.